Evidence map›Paper›PMID 42512410›Full record

ArticleCancers2026

Dissecting Immune Determinants in Lesional Skin of Cutaneous T-Cell Lymphoma During Mogamulizumab Therapy.

Xiao Ni, Wei Han, Niharika Kunta, Meghali Goswami, Jared K Burks, Ye Zheng, Youn H Kim, Madeleine Duvic

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancers, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Xiao NiDepartment of Dermatology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.ORCID 0000-0002-0154-446X
Wei HanDepartment of Dermatology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Niharika KuntaDepartment of Dermatology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Meghali GoswamiDepartment of Dermatology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Jared K BurksDepartment of Hematopoietic Biology and Malignancy, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.ORCID 0000-0002-6173-9074
Ye ZhengDepartment of Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Youn H KimDepartment of Dermatology, Stanford University School of Medicine, Stanford, CA 94305, USA.
Madeleine DuvicDepartment of Dermatology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

Funding

Tumor Evolution and Metastasis ProgramP30CA016672 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI DIANE BODURKA · 1985 to 2026
$290.8M
NCI NIH HHS P30 CA016672The University of Texas MD Anderson Cancer Center 2023-00062067The University of Texas MD Anderson Cancer Center NIH P30CA16672
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

CCR4cutaneous T-cell lymphoma (CTCL)imaging mass cytometrymogamulizumabmycosis fungoidesSézary syndrometumor microenvironment

Identifiers

PMID42512410
PMCPMC13406218

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.